USA - NASDAQ:ACXP - US00510M2035 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to ACXP. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-02-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-11 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-17 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-12-19 | HC Wainwright & Co. | Initiate | Buy |
| 2021-11-29 | Maxim Group | Initiate | Buy |
9 analysts have analysed ACXP and the average price target is 62.93 USD. This implies a price increase of 1158.68% is expected in the next year compared to the current price of 5.
The consensus rating for ACURX PHARMACEUTICALS INC (ACXP) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.